Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
23.19 USD | -4.65% | -3.38% | +193.92% |
Jun. 19 | Jasper Therapeutics, Inc. Announces Board Changes | CI |
Jun. 14 | Jasper Therapeutics, Inc. Presents Data from Preclinical Briquilimab Study at the 2024 EHA Hybrid Congress | CI |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+193.92% | 350M | |
+52.93% | 803B | |
+40.98% | 629B | |
-7.08% | 351B | |
+17.40% | 324B | |
+10.58% | 303B | |
+16.42% | 244B | |
+2.17% | 226B | |
+10.66% | 215B | |
+6.24% | 164B |
- Stock Market
- Equities
- JSPR Stock
- News Jasper Therapeutics, Inc.
- Credit Suisse Lowers Jasper Therapeutics' PT to $3 From $7 After Announcing Pipeline Reprioritization, Keeps Outperform Rating